Enter your email address in the box to the right of this page to receive email updates from the Life Sciences Hub when new content is published.
For those with an interest in life sciences, the rise to prominence of CRISPR, a transformational development in the field of molecular biology and genetics, has been impossible to ignore.
Welcome to our blog dedicated to Life Sciences. We report on EU and national regulatory, compliance, intellectual property and transactional developments in the sector. We focus on (bio)pharmaceuticals and medical technologies, and also cover food and beverages, cosmetics and other healthcare products.
06 April 2020 - Posted by: Tine Carmeliet
As in several other European countries, Belgium has a system in place to allow the temporary use of certain innovative medicines on the Belgian market when no reimbursement decision has been taken due to the therapeutic effectiveness of the medicine not yet being proven. This system of “managed entry agreements” is institutionalised through the so-called › Read More
02 April 2020 - Posted by: Eveline Van Keymeulen
On 5 February 2020, the French government introduced a wide-ranging Bill to the Senate, entitled “the acceleration and simplification of public action”, which deals with a variety of matters, including new provisions on e-commerce for medicinal products (Article 34). Currently, the online sale of medicines is highly regulated in France: only medicinal products that can › Read More
01 April 2020 - Posted by: David Shen
While the novel Covid-19 coronavirus is at the top of the agenda for businesses around the world, and for good reason, it is creating challenges for medical and healthcare systems and signalling fundamental change across the life sciences industry. Activity in China’s life sciences market remains high as one of the few sectors to › Read More
27 March 2020 - Posted by: Eveline Van Keymeulen
The French National Agency for Medicines and Health Products Safety (ANSM) recently announced the set-up of accelerated procedures for the assessment of Covid-19 treatments that are currently being developed. However, no further details regarding this accelerated procedure are publicly available. In the context of the pandemic, clinical trials for other treatments taking place in French › Read More
25 March 2020 - Posted by: Eveline Van Keymeulen
Today, on 25 March 2020, the Commission announced that “The Commission is working on a proposal to postpone the entry into force of the new Medical Device Regulation for one year. We are working hard to submit this proposal early April and we call on Parliament and on Council to adopt it quickly, as the › Read More